| 1 | The current status of anti-GPCR drugs against different cancers显示文摘G protein coupled receptors(GPCRs)have emerged as the most potential target for a number of drug discovery programs ranging from control of blood pressure,diabetes,cure for genetic diseases to treatment of cancer.A panel of different ligands including hormones,peptides,ions and small molecules is responsible for activation of these receptors.Molecular genetics has identified key GPCRs,whose mutations or altered expressions are linked with tumorgenicity.In this review,we discussed recent advances regarding the involvement of GPCRs in the development of cancers and approaches to manipulating the mechanism behind GPCRs involved tumor growth and metastasis to treat different types of human cancer.This review provides an insight into the current scenario of GPCR-targeted therapy,progress to date and the challenges in the development of anticancer drugs. | Sana Usman Maria Khawer Shazia Rafique Zara Naz Komal Saleem | 2020 | Journal of Pharmaceutical Analysis2020，10，6： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员